BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 6, 2007
View Archived Issues
Adolor Inks $265M Deal With Pfizer For Opioid
Adolor Corp.'s beleaguered shares got a 20 percent boost on Wednesday after the company announced a $265 million deal with Pfizer Inc. for the delta opioid agonists ADL5859 and ADL5747. (BioWorld Today)
Read More
Amarin Obtains MRNA Platform, Phase II Drug Via Acquisition
Read More
Bone Marrow Contributor To Tumor Vessel Growth Found
Read More
FDA Panel Votes Against Avastin Use For Breast Cancer Patients
Read More
United Kills Cancer Program Following Pivotal Trial Failures
Read More
Other News To Note
Read More
Clinic Roundup
Read More